(Q43806353)

27 November 2017

Prediction of clinical course of diffusely infiltrating astrocytomas from telomerase expression and quantitated activity level (English)

1 reference

27 November 2017

2

Atsuo Yoshino

1 reference

27 November 2017

Takao Fukushima

1

1 reference

27 November 2017

Yoichi Katayama

3

1 reference

27 November 2017

Takao Watanabe

4

1 reference

27 November 2017

Kaoru Kusama

5

1 reference

27 November 2017

Itaru Moro

6

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

27 November 2017

1 reference

27 November 2017

187

1 reference

27 November 2017

191-198

1 reference

27 November 2017

1-2

1 reference

Structure and function of telomeres

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Telomeres shorten during ageing of human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Telomere length predicts replicative capacity of human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Telomere end-replication problem and cell aging

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Telomerase activity in human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Specific association of human telomerase activity with immortal cells and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Correlating telomerase activity levels with human neuroblastoma outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Telomerase activity in human brain tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Increased expression of mutant forms of p53 oncogene in primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Differential telomerase expression in human primary intracranial tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Expression of telomerase RNA, telomerase activity, and telomere length in human gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

The significant role of telomerase activity in human brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Telomerase expression in gliomas including the nonastrocytic tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Telomerase activity in human gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Telomerase activity in 144 brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Mutations in the p53 gene occur in diverse human tumour types

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Gain of function mutations in p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900357-9

7 January 2021

10.1016/S0304-3835(02)00357-9

Identifiers

DOI

1 reference

27 November 2017

1 reference